Traditional antibody or biologics face limitations: They can be expensive to manufacture, store, and distribute; are made ...
Over 5 million people are bitten by snakes every year, according to the World Health Organization. Many effective antivenoms ...
The Indian Council of Medical Research has successfully conducted animal trials using indigenously developed monoclonal ...
The ICMR has sought collaboration with Indian industry partners for manufacturing indigenously developed monoclonal antibodies for treating deadly Nipah Virus following the successful animal trials to ...
With the T-Body platform, Invenra continues its mission to accelerate next-generation multispecific antibody discovery in areas such as oncology, autoimmune disease, and immunotherapy. The platform’s ...